-
Be prepared to cover medical research claims during election season
As the race toward the 2016 election gradually takes over more and more media coverage, Americans’ attention will be pulled…
-
Tips on using Excel to get a handle on large data files
In the age of big data and large datasets available through the CDC, the NIH, and other entities, it helps…
-
Communicating drug risks in pharma marketing: A new FDA challenge
Many American consumers may not realize this, but only New Zealand and the United States are the only countries with strong pharmaceutical regulations…
-
A guide to understanding why science is messy, hard and wonderful
An utterly fantastic long read by Christie Aschwanden at FiveThirtyEight.com, cuts to the chase very early: “Science is hard –…
-
Greater transparency is resulting in fewer ‘positive’ findings in clinical trials
If it seems the newest studies are always reporting some new link – an association between two things or an…
-
Podcast series launches with discussion of potential harms of screening tests
If you want to get a better grasp on the intricacies of screenings and assessing their risk-benefit analysis, there’s now…
-
Journalists must succeed where politicians fail in risk communication
With no new cases of Middle East respiratory syndrome (MERS) in South Korea since July 2, the outbreak appears to…
-
Freelancers face unique conflict-of-interest dilemmas
Previously, Covering Health has addressed two kinds of potential conflicts of interest that health journalists should watch out for: those of…
-
Context, context, context: How journalists can avoid confusing readers with the latest research findings
A recent editorial in the Journal of the American Medical Association explored the responsibility that journals have to public health…
-
Evidence-based reporting leads to award-winning exploration of robotic surgery
Robotic surgery has exploded in popularity in recent years, but is that because it actually improves patient outcomes over traditional…